Home › Gilead says hepatitis C treatment's approval is on track
 

Keywords :   


Gilead says hepatitis C treatment's approval is on track

2013-01-07 19:30:14| Biotech - Topix.net

Gilead Sciences is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus infection, starting in mid-2013, the Foster City biotech company said on Monday.

Tags: on track approval treatments

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05We Recycle Solar Expands Partnership with Renewables.org
20.05Washington State Authorizes Drone for Methane Emissions
20.05The Heart, Science & Business of Sustainability: A Fireside Chat with Tara Hemmer
20.05Commissioners Celebrate the Opening of New Waste Transfer Station in Redmond, Ore.
20.05Newhaven Food Waste Facility Plans Paused Following Residents Concerns
20.05Business Report May 2024Highlights from WasteExpo 2024
More »